A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Public ClinicalTrials.gov record NCT07483099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Open-Label, Active-Controlled Study to Investigate LY4395089/Mirikizumab Co-administration Compared With Mirikizumab in Adults With Moderately to Severely Active Crohn's Disease
Study identification
- NCT ID
- NCT07483099
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- LY4395089 Drug
- Mirikizumab - Intravenous (IV) Drug
- Mirikizumab - Subcutaneous (SC) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2026
- Primary completion
- May 31, 2027
- Completion
- Feb 29, 2028
- Last update posted
- Apr 20, 2026
2026 – 2028
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic in Arizona - Scottsdale | Scottsdale | Arizona | 85259 | — |
| Biopharma Informatic, LLC | Los Angeles | California | 90035 | — |
| Om Research LLC | Oxnard | California | 93030 | — |
| South Denver Gastroenterology | Englewood | Colorado | 80113 | — |
| Gastro Health Research - Miami | Miami | Florida | 33176 | — |
| Ezy Medical Research | Miami Lakes | Florida | 33015 | — |
| Atlanta Gastroenterology Associates - Peachtree Dunwoody | Atlanta | Georgia | 30342 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Cotton O'Neil Digestive Health Center | Topeka | Kansas | 66606 | — |
| Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center | Wyoming | Michigan | 49519 | — |
| KAD Clinical Research | St Louis | Missouri | 63123 | — |
| Vector Clinical Trials | Las Vegas | Nevada | 89128 | — |
| Innovo Research - Wilmington Gastroenterology Associates | Wilmington | North Carolina | 28403 | — |
| One of a Kind Clinical Research Center - Kingwood | Kingwood | Texas | 77339 | — |
| Southern Star Research Institute | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07483099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07483099 live on ClinicalTrials.gov.